Alcon

Founded in 1945 and headquartered in Geneva, Switzerland, Alcon is a leading global medical device company specializing in ophthalmology pharmaceuticals and devices. It serves the full life cycle of eye care needs through its complementary businesses in Surgical and Vision Care.

Linda Du

Director, Portfolio Strategy and New Product

Sergio Duplan

President, North America Region

Gregg Stanhope

Director, Professional Affairs, US Pharma

Stephanie Waugh

Region Vice President, Asia Pacific, Vision Care

Past deals in Laser

LENSAR

Acquisition in 2025
LENSAR, Inc. is a commercial-stage medical device company based in Orlando, Florida, established in 2004. It specializes in the design, development, and marketing of advanced femtosecond laser systems aimed at improving cataract surgery outcomes. The company's flagship product, the LENSAR Laser with Streamline IV, enhances the precision and efficiency of refractive cataract surgery by incorporating advanced features such as superior imaging capabilities and customizable treatment planning. This system assists surgeons in managing astigmatism and optimizing refractive results through innovative technology like the proprietary Augmented Reality™ 3-D model and the IntelliAxis Refractive Capsulorhexis® feature. These advancements facilitate accurate toric intraocular lens alignment and streamline surgical workflows, ultimately improving patient outcomes. LENSAR continues to expand its platform's capabilities, enabling the treatment of additional corneal conditions and enhancing the overall surgical experience for both patients and surgeons.

BELKIN Vision

Acquisition in 2024
BELKIN Vision is a company focused on developing innovative laser devices to aid healthcare professionals in the treatment of glaucoma. Its products are characterized by being non-invasive, non-contact, instantaneous, painless, and automated, providing effective laser therapy options. The company's mission is to enhance accessibility to first-line drop-less glaucoma care, enabling any ophthalmologist to effectively treat patients. By streamlining the treatment process, BELKIN Vision aims to improve patient outcomes and overall quality of care within the medical community.

LensX Lasers

Acquisition in 2010
LensX Lasers is a developer of surgical lasers used for the reparation of cataracts.

Wavelight

Acquisition in 2007
Wavelight designs, manufactures, and markets advanced laser systems for various medical, aesthetic, and industrial applications. The company specializes in ophthalmology, dermatology, and urology, offering innovative solutions that enhance the precision and effectiveness of medical procedures. Wavelight's product portfolio includes advanced diagnostic and surgical technologies aimed at correcting vision defects, such as electronic guidance systems for positioning intraocular lenses and eye-tracking systems for laser treatments. These technologies enable healthcare professionals to achieve greater accuracy and reproducibility in refractive cataract surgeries, thereby improving patient outcomes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.